Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 2,340 NXTC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | NextCure, Inc. (NXTC) | Grant/Award | 2,340 | n/a |
| Jun 18, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 25,319 | n/a |
| Jun 11, 2026 | Eloxx Pharmaceuticals, Inc. (ELOX) | Grant/Award | 13,587 | n/a |
| Jun 24, 2025 | NextCure, Inc. (NXTC) | Grant/Award | 18,700 | n/a |
| Jun 16, 2025 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 38,513 | n/a |
| Jun 27, 2024 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 15,806 | n/a |
| Jun 21, 2024 | NextCure, Inc. (NXTC) | Grant/Award | 18,700 | n/a |
| Jun 20, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 7,379 | n/a |
| Apr 30, 2024 | Gritstone bio, Inc. (GRTS) | Grant/Award | 103,600 | n/a |
| Jun 23, 2023 | NextCure, Inc. (NXTC) | Grant/Award | 14,250 | n/a |